Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
Abroad (travel likely)Active Not RecruitingPHASE1
Conditions
Uveal Melanoma · Metastatic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Study leads
Mark L McLaughlin
Study Director
Modulation Therapeutics, Inc.
Nikhil I Khushalani, MD
Principal Investigator
H. Lee Moffitt Cancer Center and Research Institute